The objective of this European multicentre study was to evaluate escitalopram efficacy and tolerability in a population which has been shown to have Treatment Resistant Depression (TRD) in a prospective open treatment phase with venlafaxine over a 6 week period at an adequate dose after non response to previous antidepressants
Latest Information Update: 16 Jul 2019
Price :
$35 *
At a glance
- Drugs Escitalopram (Primary) ; Venlafaxine
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms TRDII
- Sponsors Lundbeck A/S
- 09 Oct 2013 Results presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.
- 17 Apr 2013 New trial record